Barbara M Fischer

Summary

Affiliation: Copenhagen University Hospital
Country: Denmark

Publications

  1. ncbi request reprint [Lung cancer--should positron-emission tomography be used?]
    Barbara Malene Bjerregaard Fischer
    H S Rigshospitalet, Diagnostisk Center, klinik for klinisk fysiologi og nuklearmedicin, København
    Ugeskr Laeger 166:2537-41. 2004
  2. ncbi request reprint How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study
    Barbara M Fischer
    Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark
    Eur J Nucl Med Mol Imaging 33:697-702. 2006
  3. ncbi request reprint The future in diagnosis and staging of lung cancer: positron emission tomography
    Barbara M Fischer
    Department of Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Respiration 73:267-76. 2006
  4. ncbi request reprint PET/CT imaging in response evaluation of patients with small cell lung cancer
    Barbara M Fischer
    Department of Nuclear Medicine and PET, Centre of Diagnostic Imaging, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Lung Cancer 54:41-9. 2006
  5. ncbi request reprint A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
    B M Fischer
    Department of Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark
    Ann Oncol 18:338-45. 2007
  6. doi request reprint Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial
    Barbara M Fischer
    Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Thorax 66:294-300. 2011
  7. ncbi request reprint PET-CT in Preoperative Staging of Lung Cancer
    Barbara M Fischer
    Rigshospitalet, Copenhagen, Denmark
    N Engl J Med 364:980-1. 2011
  8. ncbi request reprint [Lung cancer--a technological challenge I. Diagnostics and staging]
    Trine Jakobi Nøttrup
    H S Rigshospitalet, Finsencentret, Onkologisk Klinik, København
    Ugeskr Laeger 166:4241-3. 2004
  9. ncbi request reprint [Lung cancer--a technological challenge II. New approaches to treatment]
    Helle Pappot
    H S Rigshospitalet, Finsencentret, Onkologisk Klinik, København
    Ugeskr Laeger 166:4243-5. 2004

Detail Information

Publications9

  1. ncbi request reprint [Lung cancer--should positron-emission tomography be used?]
    Barbara Malene Bjerregaard Fischer
    H S Rigshospitalet, Diagnostisk Center, klinik for klinisk fysiologi og nuklearmedicin, København
    Ugeskr Laeger 166:2537-41. 2004
  2. ncbi request reprint How few cancer cells can be detected by positron emission tomography? A frequent question addressed by an in vitro study
    Barbara M Fischer
    Department of Clinical Physiology, Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark
    Eur J Nucl Med Mol Imaging 33:697-702. 2006
    ..Positron emission tomography (PET) has gained widespread use in cancer diagnosis and treatment, but how many malignant cells are required for a tumour to be detected by PET?..
  3. ncbi request reprint The future in diagnosis and staging of lung cancer: positron emission tomography
    Barbara M Fischer
    Department of Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Respiration 73:267-76. 2006
    ....
  4. ncbi request reprint PET/CT imaging in response evaluation of patients with small cell lung cancer
    Barbara M Fischer
    Department of Nuclear Medicine and PET, Centre of Diagnostic Imaging, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Lung Cancer 54:41-9. 2006
    ..However, data on SCLC is scarce and mainly retrospective. This prospective study assesses the use of PET (positron emission tomography) and PET/CT in response evaluation of patients with small cell lung cancer (SCLC)...
  5. ncbi request reprint A prospective study of PET/CT in initial staging of small-cell lung cancer: comparison with CT, bone scintigraphy and bone marrow analysis
    B M Fischer
    Department of Nuclear Medicine and PET, Copenhagen University Hospital, Copenhagen, Denmark
    Ann Oncol 18:338-45. 2007
    ..Small-cell lung cancer (SCLC) accounts for 15%-20% of all lung cancer cases. Accurate and fast staging is mandatory when choosing treatment, but current staging procedures are time consuming and lack sensitivity...
  6. doi request reprint Multimodality approach to mediastinal staging in non-small cell lung cancer. Faults and benefits of PET-CT: a randomised trial
    Barbara M Fischer
    Department of Clinical Physiology, Nuclear Medicine and PET, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark
    Thorax 66:294-300. 2011
    ..The objective of this study was to describe faults and benefits of positron emission tomography (PET)-CT in multimodality mediastinal staging...
  7. ncbi request reprint PET-CT in Preoperative Staging of Lung Cancer
    Barbara M Fischer
    Rigshospitalet, Copenhagen, Denmark
    N Engl J Med 364:980-1. 2011
    ..The primary end point of our study was the number of futile thoracotomies that had been performed, as determined by the intention-to-treat analysis. Thus, the error does not change the published outcome. We . . ...
  8. ncbi request reprint [Lung cancer--a technological challenge I. Diagnostics and staging]
    Trine Jakobi Nøttrup
    H S Rigshospitalet, Finsencentret, Onkologisk Klinik, København
    Ugeskr Laeger 166:4241-3. 2004
  9. ncbi request reprint [Lung cancer--a technological challenge II. New approaches to treatment]
    Helle Pappot
    H S Rigshospitalet, Finsencentret, Onkologisk Klinik, København
    Ugeskr Laeger 166:4243-5. 2004